Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
Solace Health, a company that connects patients with an "advocate" to help them navigate the U.S. healthcare system after a diagnosis, announced on Tuesday that it's earned $130 million in Series C funding, bringing its valuation to the coveted “unicorn status."
The insurer said Google’s Gemini was part of the new AI’s core development. The system will support customer service interactions by automatically summarizing calls and pulling up relevant information, without the need for manual input. The Google Cloud will be providing the necessary data security to ensure patient privacy, the companies added.
A report from Gibbins Advisors found that, overall, the healthcare space is feeling the stress of economic chaos, including Medicaid cuts, tariffs and high interest rates.
The new tool received $25,000 in funding after winning the grand prize in a Veterans Day pitch contest. Currently in a pilot phase, the website will help troops find shelter, be it temporary or permanent.
Some of the claims in the lawsuit, brought against Novant Health by Kyle Horton, MD, are backed by a report from the North Carolina Department of Health and Human Services.
The agencies said private equity firms are rolling up healthcare sectors through serialized purchases that fly under the radar of regulators, creating an unsustainable level of consolidation.
A new report from the Office of the Inspector General found the FDA failed to properly record meetings with drug manufacturers, ultimately approving drugs later shown to have safety and efficacy issues.
The integration was announced during the annual JP Morgan Health Care Conference in San Francisco. The program works through Amazon Benefits Manager to remotely help patients with weight and blood pressure management.
The drug Caplyta, owned by Intra-Cellular Therapies, is being used to treat bipolar disorder and schizophrenia. In 2024, it brought in more than $481 million in sales.